Cancel
About Tim Crew
Tim Crew is the Chief Executive Officer who led the successful FDA first-cycle approval for Mycophenolate Mofetil for Oral Suspension.
Known information
Tim Crew serves as the Chief Executive Officer and has played a pivotal role in achieving a significant milestone for his company. He successfully led the team that secured the FDA first-cycle approval for Mycophenolate Mofetil for Oral Suspension. This approval marked a notable achievement in introducing a new dosage form, enhancing the company’s product portfolio and demonstrating effective leadership in navigating complex regulatory environments.
About Lannett Company
Lannett Company, founded in 1942 and based in Trevose, PA, manufactures a diverse range of generic pharmaceutical products and is committed to environmental sustainability and ethical business practices.
Report inaccurate information
